Table 3 Outcomes of anti-Jo1 patients with antisynthetase syndrome a
From: Functional outcome and prognostic factors in anti-Jo1 patients with antisynthetase syndrome
Outcomes | Data, n(%) |
|---|---|
Resolution | 13 (15.1%) |
Improvement | 55 (63.9%) |
Deterioration | 18 (20.9%) |
ASS course | Â |
 Monocyclic | 1 (1.2%) |
 Chronic continuous | 56 (65.1%) |
Recurrences | Â |
 During tapering of high-dose steroids | 5 (5.8%) |
 During tapering of low-dose steroids | 69 (80.2%) |
 Off treatment | 1 (1.2%) |
 Mortality | 10 (11.6%) |